Trial Design Solutions

  1. Tumor Mutational Burden (TMB) Assay For Response To Immunotherapy
    6/14/2018

    Enable sensitive mutation detection for quantifying TMB across various tumor indications.

  2. Bioanalytical & ADME Laboratory Services
    6/14/2018

    Global industry-leading expertise and resources to help support high quality delivery of routine and complex bioanalytical and ADME projects for our customers.

  3. Site and Patient Solutions
    5/22/2018

    ICON's proven site and patient recruitment paradigm bridges the gap between patients and clinical research sites.

  4. Patient Insights And Engagement
    5/22/2018

    Bringing the patient’s perspective into all phases of development.

  5. Worldwide Evidence™: Advancing Science and Strategy at Every Stage of the Product Life Cycle
    5/15/2018

    Transform data into persuasive evidence to document the clinical, economic, and humanistic value of innovative drugs and devices before and after product approval and launch. Ready to learn how?

  6. Medical Writing and Publishing
    5/15/2018

    Medical and regulatory documentation developed by experienced medical writing teams plays a pivotal role in the success of a clinical research project.

  7. FLEX ADVANTAGE™
    5/15/2018

    Flex Advantage offers enhanced randomization, clinical supply management capabilities and enables the execution of adaptive clinical trials.

  8. FLEX ADVANTAGE Interactive Response Platform
    5/15/2018

    Executing efficient and compliant adaptive trials,

  9. DIA 2018 Preliminary Program
    4/27/2018

    The DIA 2018 Global Annual Meeting is shaping up to be the Life Sciences Event of the Year! Download this year's Preliminary Program to learn why! Get the highlight reel of DIA 2018.

  10. Optimizing Your Supply Chain Management
    4/2/2018

    How a powerful forecasting and demand planning technology for managing the end-to-end clinical supply chain can quickly simulate the most common scenarios for each step of your study, create a study baseline and forecast randomization into different dosing groups.